US Patent Issued to NIBEC on Aug. 4 for "Bone morphogenetic protein-9 and -10 variants with enhanced therapeutic effect due to reduced side effects of ectopic ossification and pharmaceutical composition comprising same" (South Korean Inventors)

ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,698,313, issued on Aug. 4, was assigned to NIBEC Co. LTD. (Chungcheongbuk-Do, South Korea).

"Bone morphogenetic protein-9 and -10 variants with enhanced therapeutic effect due to reduced side effects of ectopic ossification and pharmaceutical composition comprising same" was invented by Chong-Pyoung Chung (Seoul, South Korea), Yoon Jeong Park (Seoul, South Korea), Jue-Yeon Lee (Gyeonggi-do, South Korea), Gook-Jin Yoon (Seoul, South Korea) and Dong Woo Lee (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a BMP-9 variant and a derivative thereof. The variant stimulates endothelial cell-specific signaling, ...